Biosimilars: US FDA Heralds The End Of Switching Studies For Interchangeability

 
• By David Wallace
Red on off switch
The FDA is switching off the requirement for switching studies • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics